|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"peng"
Showing items 56-65 of 276 (28 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024-01 |
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program
|
Lu;Ming-Ying;Huang;Chung-Feng;Hung;Chao-Hung;Tai;Chi-Ming;Mo;Lein-Ray;Kuo;Hsing-Tao;Tseng;Kuo-Chih;Lo;Ching-Chu;Bair;Ming-Jong;Wang;Szu-Jen;Huang;Jee-Fu;Yeh;Ming-Lun;Chen;Chun-Ting;Tsai;Ming-Chang;Huang;Chien-Wei;Lee;Pei-Lun;Yang;Tzeng-Hue;Huang;Yi-Hsiang;Chong;Lee-Won;Chen;Chien-Lin;Yang;Chi-Chieh;Yang;Sheng-Shun;Cheng;Pin-Nan;Hsieh;Tsai-Yuan;Hu;Jui-Ting;Wu;Wen-Chih;Cheng;-Yu, Chien;Chen;Guei-Ying;Zhou;Guo-Xiong;Tsai;Wei-Lun;Kao;Chien-Neng;Lin;Chih-Lang;Wang;-Chi, Chia;Lin;Ta-Ya;Lin;Chih-Lin;Su;-Wen, Wei;Lee;Tzong-Hsi;Chang;Te-Sheng;Liu;Chun-Jen;Dai;-Yen, Chia;Kao;Jia-Horng;Lin;Han-Chie;Chuang;-Long, Wan;Peng;Cheng-Yuan;Tsai;Chun-Wei;Chen;Chi-Yi;Yu;Ming-Lung |
| 國立成功大學 |
2024 |
Highly conductive riboflavin-based carbon quantum dot–embedded SiO2@MoS2 nanocomposite for enhancing bioelectricity generation through synergistic direct and indirect electron transport
|
Kuo;Y, -H.;Hsu;M, -C.;Wang;W, -J.;Peng;H, -H.;Li;W, -P. |
| 國立成功大學 |
2024 |
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination with Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection among People with HIV
|
Lin;K, -Y.;Sun;H, -Y.;Yang;C, -J.;Lu;P, -L.;Lee;Y, -T.;Lee;N, -Y.;Liou;B, -H.;Tang;H, -J.;Lee;M, -H.;Wang;N, -C.;Chen;T, -C.;Hii;I, -M.;Huang;S, -H.;Lin;C, -Y.;Tsai;C, -S.;Cheng;C, -Y.;Hung;C, -C.;Chang;S, -Y.;Huang;Y, -S.;Chen;G, -J.;Wu;P, -Y.;Chen;L, -Y.;Chang;H, -Y.;Liu;W, -C.;Su;Y, -C.;Lin;T, -Y.;Tsai;M, -S.;Lee;Y, -C.;Cheng;S, -H.;Huang;Y, -C.;Peng;A, -T.;Lee;Y, -L.;Lin;C, -C.;Lin;S, -P.;Hsieh;C, -Y.;Wang;H, -W.;Ho;M, -W.;Liu;C, -E.;Hung;T, -C.;Chen;Y, -H.;Lee;C, -Y.;Tsai;H, -C.;Lin;H, -H.;Lee;C, -H. |
| 國立成功大學 |
2024 |
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C
|
Hong;C, -M.;Su;T, -H.;Hsu;S, -J.;Tseng;T, -C.;Liu;C, -H.;Yang;H, -C.;Kao;J, -H.;Chen;P, -J.;Cheng;P, -N.;Hung;C, -H.;Peng;C, -Y.;Chen;C, -H.;Lin;C, -Y.;Kuo;H, -T.;Lin;H, -C.;Huang;Y, -H.;Chen;C, -Y.;Lin;C, -L.;Tsai;P, -C.;Zeng;Y, -S.;Dai;C, -Y.;Chuang;W, -L.;Huang;J, -F.;Huang;C, -F.;Yeh;M, -L.;Yu;M, -L.;Liu;C, -J. |
| 國立成功大學 |
2024 |
Age at onset of type 1 diabetes between puberty and 30�years old is associated with increased diabetic nephropathy risk
|
Lin;Y, -B.;Chang;T, -J.;Sheu;W, H.-H.;Lo;S, -H.;Yeh;Y, -P.;Huang;C, -N.;Hwu;C, -M.;Hsieh;C, -H.;Ou;H, -Y.;Chuang;L, -M.;Chen;J, -F.;Chen;Y, -C.;Peng;Y, -H.;Chen;S, -T.;Hsu;S, -R.;Hsieh;Y, -L.;Chu;C, -H.;Lu;C, -H.;Lee;Y, -J.;Chen;H, -F.;Chen;C, -C.;Lee;C, -C.;Hsiao;P, -J.;Tsai;S, -T.;Chen;S;Su;C, -C.;Lin;Y, -L.;Bau;C, -T.;Liao;C, -C.;Kuo;T, -Y.;Chen;H, -J.;Wang;C, -C.;Cheng;C, -J.;Lin;Y, -L.;Chen;S, -C.;Chen;C, -Y.;Huang;H, -Y.;Chen;J, -R.;Lo;H, -J.;Yu;N, -C.;Liu;W, -C.;Wu;C, -H.;Chen;D, -W.;Shen;D, -C.;Chung;W, -C. |
| 國立成功大學 |
2024 |
Clinical care guidance in patients with diabetes and metabolic dysfunction–associated steatotic liver disease: A joint consensus
|
Huang;J, -F.;Chang;T, -J.;Yeh;M, -L.;Shen;F, -C.;Tai;C, -M.;Chen;J, -F.;Huang;Y, -H.;Hsu;C, -Y.;Cheng;P, -N.;Lin;C, -L.;Hung;C, -H.;Chen;C, -C.;Lee;M, -H.;Lee;C, -C.;Lin;C, -W.;Liu;S, -C.;Yang;H, -I.;Chien;R, -N.;Kuo;C, -S.;Peng;C, -Y.;Chang;M, -L.;Huang;C, -F.;Yang;Y, -S.;Yang;H, -C.;Lin;H, -C.;Ou;H, -Y.;Liu;C, -J.;Tseng;C, -H.;Kao;J, -H.;Chuang;W, -L.;Huang;C, -N.;Chen;P, -J.;Wang;C, -Y.;Yu;M, -L. |
| 國立成功大學 |
2024 |
Phase 1 trial of the safety, pharmacokinetics, and anti-viral activity of edp-514 in untreated viremic chronic hepatitis b patients
|
Yuen;M, -F.;Chuang;W, -L.;Peng;C, -Y.;Jeng;W, -J.;Su;W, -W.;Chang;T, -T.;Chen;C, -Y.;Hsu;Y, -C.;Rosa, de la;G;Ahmad;A;Luo;E;Conery;A, L. |
| 國立成功大學 |
2024 |
Consensus on COVID-19 vaccine recommendations: Challenges and strategies for high-risk populations in Taiwan
|
Wu;C, -H.;Hung;W, -C.;Huang;C, -F.;Liu;Y, -T.;Cheng;S, -Y.;Chang;C, -J.;Peng;L, -N.;Yen;C, -H.;Huang;C, -K. |
| 國立成功大學 |
2024 |
Taiwan Association for the Study of the Liver-Tai-wan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction-associated fatty liver disease and cardiovascular diseases
|
Cheng;P, -N.;Chen;W, -J.;Hou;C, J.-Y.;Lin;C, -L.;Chang;M, -L.;Wang;C, -C.;Chang;W, -T.;Wang;C, -Y.;Lin;C, -Y.;Hung;C, -L.;Peng;C, -Y.;Yu;M, -L.;Chao;T, -H.;Huang;J, -F.;Huang;Y, -H.;Chen;C, -Y.;Chiang;C, -E.;Lin;H, -C.;Li;Y, -H.;Lin;T, -H.;Kao;J, -H.;Wang;T, -D.;Liu;P, -Y.;Wu;Y, -W.;Liu;C, -J. |
| 國立成功大學 |
2024 |
Study on the Influence of Runner and Overflow Area Design on Flow–Fiber Coupling in a Multi-Cavity System
|
Hsieh;F, -L.;Chen;C, -T.;Hwang;S, -S.;Hwang;S, -J.;Huang;P, -W.;Peng;H, -S.;Jien;M, -Y.;Huang;C, -T. |
Showing items 56-65 of 276 (28 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
